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Background: Since Kanner’s first description of autism there have been a number of changes in approaches to
diagnosis with certain key continuities . Since the Fourth edition of the Diagnostic and Statistical Manual (DSM-IV)
appeared in 1994 there has been an explosion in research publications. The advent of changes in DSM-5 presents
some important moves forward as well as some potential challenges.
Methods: The various relevant studies are summarized.
Results: If research diagnostic instruments are available, many (but not all) cases with a DSM-IV diagnosis of autism
continue to have this diagnosis. The overall efficiency of this system falls if only one source of information is
available and, particularly, if the criteria are used outside the research context. The impact is probably greatest
among the most cognitively able cases and those with less classic autism presentations.
Conclusions: Significant discontinuities in diagnostic practice raise significant problems for both research and
clinical services. For DSM-5, the impact of these changes remains unclear.
Keywords: Autism spectrum disorders, diagnosis, DSM-IV, DSM-5Introduction
Commonality in approaches to classification help us
communicate more effectively about clinical problems
(rapidly conveying a general sense of the kinds of diffi-
culties exhibited) and conduct better research by insur-
ing comparability of samples across sites and countries.
As Rutter and Schopler noted, there is not a single, simple,
right way to approach this task [1,2] and, for psychiatric
and developmental disorders, a range of approaches have
been developed. Official diagnostic systems, such as the
World Health Organization’s International Classification of
Diseases (ICD-10) and the American Psychiatric Associa-
tions Diagnostic and Statistical Manual, fourth edition
(DSM-IV), have usually been oriented around specific
categories but have increasingly also included dimensional
approaches to provide better characterization. Before
autism was first recognized officially by the Diagnostic and
Statistical Manual, third edition (DSM-III) in 1980, it was
very difficult to be sure of the comparability of samples;
this hindered the ability to synthesize findings across
studies and hampered research. Since the alignment of
diagnostic criteria of DSM-IV and ICD-10, there has been* Correspondence: fred.volkmar@yale.edu
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distribution, and reproduction in any mediuman explosion of research – with well over 2,000 peer-
reviewed scientific papers published last year, an increase
from fewer than 2,000 peer-reviewed papers published in
the decade before DSM-IV/ICD-10, highlighting the utility
of such an alignment.
Various interests must be balanced in designing official
systems; for example, reliability and ease of use, differen-
tiation of categories, and consideration of developmental
issues [3]. Probably the major difference between ICD-
10 and DSM-IV is the provision in ICD-10 of separate
guidelines for research and clinical work while DSM-IV
provides one set of guidelines for both purposes. Other
differences include issues of comorbidity, impairment
requirements, and implications for service eligibility.
This paper reviews recent developments in the diagno-
sis of autism in Diagnostic and Statistical Manual, fifth
edition (DSM-5). We begin with a short review of the
history of diagnostic approaches, the rational for the
DSM-5 model, and a discussion of its uses and
limitations.
Diagnosis of autism from Kanner to DSM-IV
The condition known as autistic disorder, childhood
autism, or infantile autism was first described by Kanner
in his report of 11 children with what appeared to him
to be a novel condition characterized by two essentiald Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and a group of behaviors he referred to as ‘resistance to
change’ or ‘insistence on sameness’ [4]. Kanner’s
thoughtful clinical description noted many of the
features still commonly included in diagnostic criteria
for the disorder, and his emphasis on the centrality of
social difficulties remains a hallmark of the condition.
Early research was confused by some false leads and a
lack of clarity about the validity of autism (as compared
with childhood schizophrenia). By the 1970s longitudinal
and other studies strongly suggested the validity of the
condition, its frequent association with intellectual
disability, and its strong brain [5] and genetic basis [6].
As research accumulated it also became clear that
language-communication problems were a major source
of disability, so that by the late 1970s there was a
consensus that autism was characterized by: impaired
social development of a type quite different from that in
normal children; impaired language and communication
skills – again of a distinctive type; resistance to change
or insistence on sameness, as reflected in inflexible
adherence to routines, motor mannerisms, and stereoty-
pies, and other behavioral oddities; and an onset in the
first years of life. Available research strongly supported
inclusion of autism as a new condition in DSM-III,
which had adopted an atheoretical research diagnostic
criteria approach [3].
In DSM-III autism was included in a class of condi-
tions called pervasive developmental disorder (PDD);
this term had the advantage of no previous history. The
DSM-III definition was very focused on infantile autism
and developmental change was only cursorily addressed,
although other categories for late-onset autism were also
included (although without much justification) [3].
In DSM-III-R (1987) there was a major attempt to
address the lack of developmental orientation. A single
disorder and a subthreshold category were described
(the name of the latter was changed from atypical PDD
to pervasive developmental disorder not otherwise speci-
fied (PDD-NOS)). The criteria set was more extensive
than in DSM-III and included a polythetic definition
with symptoms chosen from social, communication, and
resistance to change categories. Although a field trial was
conducted it was limited in some ways and, in retrospect,
DSM-III-R appeared to overdiagnose autism in individuals
with greater cognitive disability while, to some extent,
underdiagnosing at the other end of the IQ range [3].
For DSM-IV a number of preliminary steps were
undertaken, including invited reviews of the literature,
data reanalysis, and, finally, a large multi-site field trial
conducted with over 100 raters of nearly 1,000 cases in
various (20+) sites around the world. Goals for DSM-IV
included balancing sensitivity and specificity across the
IQ range and age, convergence (if possible) with theICD-10 diagnostic approach, and potentially including
new disorders in the DSM-IV definition [7].
The final definition for autism was polythetic, had a
good balance of sensitivity and specificity, and im-
proved reliability in less experienced evaluators. DSM-
IV also recognized three disorders new to DSM: child-
hood disintegrative disorder, Asperger’s disorder, and
Rett’s disorder along with the usual subthreshold PDD-
NOS category. Of these conditions, the definition of
Asperger’s proved most problematic (the text was
radically changes at the time DSM-IV-TR appeared but
the criteria could not be changed at that point). As a
result the concept has been used inconsistently
although research on it has increased dramatically [8].
Rett’s disorder was included because it appeared to be a
very interesting condition that might have a specific
neurobiological basis and the PDDs seemed the best place
for it [9]; subsequently, a gene has been discovered for this
condition and it is often no longer regarded as an autism
spectrum disorder, although draft versions of DSM-5 have
included it as a specifier. Childhood disintegrative disorder
was of great interest, despite its rarity, in that a child
would develop typically to 4 years, 5 years, or even 6 years
of age before having a rapid and dramatic regression
followed by a more classic autism presentation [2]. DSM-
IV/ICD-10 did come to convergent definitions, and the
approach has been widely used and highly productive for
research. This approach also facilitated the development
of new dimensional approaches for screening and diagno-
sis that further enhanced research.Review
DSM-5 and autism
As with DSM-IV, the task of revision for DSM-5 was
taken seriously by the overall work group and members
of the committee on neurodevelopmental disorders. Sev-
eral key executive decisions adopted for all of DSM-5
have had serious implications; these are the decision to
eliminate subthreshold categories and the high reliance
on diagnostic instruments as a source of criteria and as
proof of validity [10]. Issues more specific to autism
include the nature of the revision and decisions about
how best to outline and organize the proposed criteria
and evaluate them.
Some aspects of the DSM-5 approach to autism
appear to be well reasoned and quite valuable; for
example, the move to a better description of the class of
disorder (autism spectrum disorder to replace PDD) and
the use of dimensions in combination with categorical
approaches. Some of the more practical problems, how-
ever, probably arise in the context of the revision
process, and the final product has been the subject of
much debate [11,12].
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disorders included in DSM-IV in favor of a single autism
spectrum term. A second disorder, social (pragmatic)
communication disorder, was added, although its rela-
tion to the autism spectrum disorders (ASD) remains
unclear (ASD must be ruled out in the diagnostic
criteria, but prevalence estimates of ASD have included
social (pragmatic) communication disorder). Also un-
clear is the application and use of this diagnosis in
practice and the types of services to which an individual
might be entitled. In combination with the use of better
specifiers of dimension it was hoped that clinical needs
would be well served. Given its single-gene etiology, a
decision was also made to remove Rett’s disorder from
DSM, although an individual with this genetic condition
meeting diagnostic criteria for ASD would still receive
an ASD diagnosis probably with a specifier. This is a
complicated precedent given the many strong leads it
has provided in uncovering the genetics of autism. While
a case clearly could have been made for refining the
Asperger’s label, the work group elected to eliminate it
as a category along with childhood disintegrative dis-
order. In some respects both moves are controversial,
particularly given the inconsistency with which the
Asperger’s diagnosis has been utilized (itself a problem
but potentially one obscuring a potentially important
clinical distinction). Based on a factor analysis of a large
body of data from diagnostic instruments a decision was
made to collapse social and communication features into
a single category and then to have a second category
more consistent with Kanner’s ‘insistence on sameness’/
restricted interests package with the addition of a
sensory sensitivity symptom, which had poor specificity
in the DSM-IV field trial [7,13].
Factor analysis methods have their uses and limitations –
depending at the most basic level on which data are
included in the analysis and how the analysis is
constrained. For the DSM-IV field trial either a two-factor,
three-factor or five-factor solution could be derived;
others performing similar analyses have noted the
complexity of these approaches [14]. The final decision
for DSM-IV and ICD-10 to keep the traditional three
categories (dating back to Rutter’s 1978 definition [15])
was made partly for reasons of historical continuity and,
strategically, having three categories of criteria gave many
different combinations of criteria that would yield an
autism diagnosis (well over 2,000).
There is no question that social and communicative
features are very closely related, but the problem in
combining them into one category results in many fewer
potential criteria combinations. Another factor contri-
buting to the decreased combinations of symptoms is
the move back to a monothetic approach for the social
communication domain, where instead of two out offour criteria and one out of four criteria required in the
DSM-IV, three out of three criteria are required in the
DSM-5. A polythetic approach was retained for the
repetitive and restrictive behavioral domain, although
the number of symptoms needing to be met was
increased from one out of four (zero of four potentially
in PDD-NOS) to two out of four. We are not advocating
for one approach over the other; they each have advan-
tages and disadvantages and are often used together for
diagnostic criteria [16]. Rather, we are illustrating the
impact that this decision is likely to have on the com-
position of the autism spectrum, which might more
closely resemble the more classic autism described by
Kanner [4] than the broader autism spectrum that might
be captured with polythetic criteria. An additional
consequence of requiring all three social criteria could
be the delayed diagnosis (and consequentially the delay
of intervening) for children whose symptoms do not
fully manifest until social demands increase.
Data from a large series of well-characterized cases
were used to produce the draft DSM-5 criteria for the
single new autism spectrum disorder. Two research
diagnostic instruments (one a parent report measure
and the other observational assessment) were used [17].
The authors rightly noted that this was not a field trial,
and their results suggested that when both the parent
interview and child assessment were conducted, sensiti-
vity/specificity were maximized; however, in the absence
of both, specificity fell. Their data suggested that no
more than about 10% of cases would lose their diagnosis.
Other data on reliability were also provided from a field
trial focused only on this issue [18], although the overall
approach to the DSM-5 field trial has also been criti-
cized [19,20]. Other data using large datasets have also
provided some support to the approach undertaken [21].
Given the data available and the major effort under-
taken, then, what are the potential problems?
Issues in use of DSM-5
Despite the name change to autism spectrum disorder,
the concept actually proposed is apparently more
restricted than the DSM-IV approach. A series of papers
using different approaches and different samples suggest
that the issue may be more extensive than would other-
wise be thought. If the results of these studies are
realized, there would probably be large implications for
service eligibility and research for individuals currently
receiving support for the disorder. It is important to
note in moving DSM-5 into what may be more real-
world clinical settings that practitioners will not
likely have had the extensive training in diagnostic
instruments.
The results of most of the relevant independent stu-
dies can be succinctly summarized. It is important to
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earlier version of DSM-5 and that diverse methods and
samples were used. Mattila and colleagues used a slightly
earlier draft of DSM-5 to assess agreement with DSM-
IV [22]. In this epidemiological study a very large sample
of 8-year-old children were assessed using the Autism
Spectrum Screening Questionnaire and 110 were then
seen for more in-depth assessment. The investigators
noted that DSM-5 was less sensitive than DSM-IV.
Comparisons were also made between DSM-IV and
DSM-5, showing individuals with higher IQs being less
likely to meet the new diagnostic criteria.
Similarly, Worley and Matson compared symptoms of
ASD in several hundred children using DSM-IV and
DSM-5. Significant differences were noted in terms of
core domain scores on socialization/communication
between DSM-IV and DSM-5 [23]. In both cases the
groups had significantly higher levels of dysfunction than
a control group and the number no longer meeting
criteria in DSM-5 was noted to be a potential problem
for both clinical service provision and research; for
example, relative to epidemiological or longitudinal
studies.
Frazier and colleagues evaluated proposed DSM-5
criteria in a large sample of siblings (some with ASD
and others without ASD) [21]. They noted that in this
sample of children (ages 2 to 18) the specificity of DSM-
5 was higher than that of DSM-IV while sensitivity was
lower and that relaxing the diagnostic threshold might
improve the approach.
McPartland and colleagues reanalyzed a large sample
of cases selected from the DSM-IV field trial [24]. Sensi-
tivity and specificity were systematically assessed using a
symptom checklist approach to cross-walk DSM-IV
criteria to DSM-5. The specificity of DSM-5 was high
(94.9%) but sensitivity varied dramatically by clinical
group (varying from 0.76 in autism to 0.25 in Asperger’s
disorder and 0.28 in PDD-NOS) and by cognitive ability
(IQ <70 = 0.70; IQ ≥70 = 0.46).
Mattson and colleagues examined alternative ap-
proaches to improve DSM-5 [25]. They evaluated two
potential modifications for toddlers, with some degrees
of overall improvement but with significant numbers of
toddlers apparently left without eligibility for services.
They noted that while excluded from the diagnostic
categories these toddlers continued to exhibit significant
impairment.
Gibbs and colleagues compared DSM-IV-TR and
DSM-5 diagnosis in a sample of 132 children [26]. Of
the 111 who had received a diagnosis of autism or
related PDD in DSM-IV-TR, 26 did not meet the criteria
in DSM-5; most of those excluded from ASD in DSM-5
would have received a diagnosis of PDD-NOS in DSM-
IV-TR.Taheri and Perry reviewed over 130 cases of children
with previous diagnosis of autism or PDD-NOS and
found that about 60% met the new DSM-5 criteria (81%
of those with autism but less than 20% of those with
PDD-NOS) [27]. They also noted a significant relation-
ship to IQ, with more able cases more frequently losing
a diagnosis.
Most recently, Wilson compared DSM-IV, ICD-10,
and DSM-5 in a sample of 150 adults with ASD who
were more cognitively able [28]. The author noted that
about 56% of those meeting ICD-10 also met DSM-5
(although nearly 20% of those not meeting criteria for
ASD met DSM-5 criteria for social communication
disorder). They noted that this might be an important
practical problem in terms of access to service and sug-
gested modification either in the diagnostic threshold
(reducing the number of criteria required) or in giving
greater leniency to uncertain criteria (allowing them to
count). While the first of these proposals would be rela-
tively easy to implement, the second poses significant
difficulty. As the authors emphasized, exclusion from
clinical services is a potentially significant problem.
On the other hand, Mazefsky and colleagues compared
DSM-IV and DSM-5 diagnosis using the research instru-
ments on which the new DSM-5 approaches is based
[29]. They found that 93% of the nearly 500 high-
functioning participants met the criteria for autism in
DSM-5 but that this number was lower when only the
parent instrument used and lower still if only the
individual assessment was available. While reassuring
from the point of view of research, if both instruments
are available it is worrisome that, in practice, for adults a
parental informant may not be available.
What do all these results mean?
As noted previously there are some very sensible and
praiseworthy aspects of DSM-5. The decision to elimi-
nate subcategories is controversial, and the important
thing is that individuals who need and benefit from ser-
vices are still able to obtain these services. It is also im-
perative that we do not have major changes in research
diagnosis. This would pose a significant challenge for
many studies; for example, those with epidemiological or
longitudinal samples, or studies of treatments that span
decades. It is also unclear what changes will be made in
ICD-11 and a lack of alignment of the international and
American definitions could impact research. It would
seem to be important to base what may be significant
change on a very solid body of data.
One might ask what we really know the actual impact
of DSM-5 will be. The simple response is that we do not
know [30]. As we have outlined, a series of studies
suggest that many children might no longer meet the
diagnostic criteria of ASD. Less is known about very
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provide early intervention services when the brain has
its most plasticity, or adults, who are an understudied
population in which little is known regarding best
practice. A very recent study has suggested that the
DSM-5 approach is overly restrictive with this age group
as well and became adequate only when scoring rules
were modified [31].
Conclusions
Since the appearance of DSM-IV in 1994, research on
autism and related conditions has expanded dramati-
cally. Part of this expansion reflects the consensus on
diagnosis exemplified by the convergence of DSM-IV
and ICD-10 and a more flexible diagnostic approach
than employed by its predecessors. As with any human
construction there is no question that sensible changes
can and should be made. On the other hand, there is
also a tension around being overly enthralled with
change given the potential for complicating past work,
ongoing longitudinal and epidemiological studies, and
service provision.
While some of the changes employed in the new
DSM-5 approach are praiseworthy, others are much
more complicated. There appears to be some significant
potential for diagnostic change, essentially as – despite
what might conceptually appear to be a broader tent of
the autism spectrum – the DSM-5 approach seems likely
to result in a narrower concept. This raises some
concern about the impact on services for children in
need as well as for comparison with previous research.
Sadly we are, to a considerable extent, still in the dark
on the extent of this change. Although the focus on
standardized diagnostic instruments has some important
advantages in the real world of clinics and schools,
clinicians will not have had the opportunity to undertake
extensive training. In some cases the new (but relatively
unclear) social communication disorder concept may be
invoked, but the lack of research on this putative
condition poses other problems and its use might well
be taken as an excuse to avoid service provision.
These are clear areas where future research will be
needed. Aside from these unknowns, it seems likely that
some proportion of the cases will lose their label and
thus potentially lose their eligibility for services. If this
proves correct, then this is a drastic change both from
the service and research points of view. While some
aspects of the new approach clearly have considerable
merit, the lack of data on this most fundamental issue is
problematic. It is possible that the issue is much less
significant for research centers where trained examiners
are available and when both parent interview and
individual assessment research instruments are available.
However, given that the Diagnostic and StatisticalManual is intended for use in the actual clinical world
(for example, a psychiatrist’s practice in a suburban
American town, a pediatric nurse conducting a level-one
screener in an inner-city health clinic on a 18-month-old
child, at a 10-minute 4-year annual evaluation), the issue
of its impact on eligibility remains to be seen. We will
only know this after prospective studies conducted in
community-based sites (not university clinics) report com-
parisons between DSM-IV and DSM-5 criteria. Hopefully
once DSM-5 has appeared and is used in practice, these
issues will be clarified and, if need be, revisions can rapidly
be made.
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